The cell cycle: A critical therapeutic target to prevent vascular proliferative disease
- 1 February 2006
- journal article
- review article
- Published by Elsevier BV in Canadian Journal of Cardiology
- Vol. 22, 41B-55B
- https://doi.org/10.1016/s0828-282x(06)70986-2
Abstract
No abstract availableKeywords
This publication has 186 references indexed in Scilit:
- Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: Results of the randomized investigation by the thoraxcenter of antisense dna using local delivery and ivus after coronary stenting (ITALICS) trialJournal of the American College of Cardiology, 2002
- Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicityOncogene, 2001
- Expression of Interleukin-1β, Interleukin-1 Receptor, and Interleukin-1 Receptor Antagonist mRNA in Rat Carotid Artery after Balloon AngioplastyBiochemical and Biophysical Research Communications, 2000
- Relationship between cell migration and cell cycle during the initiation of epithelial to fibroblastoid transitionCell Motility, 1999
- Pathobiologic Responses to StentingThe American Journal of Cardiology, 1998
- Intravascular Ultrasound to Discern Device-Specific Effects and Mechanisms of RestenosisThe American Journal of Cardiology, 1996
- Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.JCI Insight, 1995
- Suppression of Neointimal Smooth Muscle Cell Accumulation in Vivo by Antisense cdc2 and cdk2 Oligonucleotides in Rat Carotid ArteryBiochemical and Biophysical Research Communications, 1994
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993
- Role for cyclin A in the dependence of mitosis on completion of DMA replicationNature, 1991